Nadmierna potliwość (hiperhidroza)
Epidemiologia
Hiperhidroza, definiowana jako patologiczne nadmierne pocenie się przekraczające potrzeby termoregulacyjne, dotyka globalnie od 2% do 4% populacji, choć nowsze badania wskazują na wyższe wartości, np. 2,8-4,8% w USA (7,8-15,3 mln osób) czy 5,5% w Szwecji z 1,4% ciężkich przypadków. Występuje bez wyraźnej predylekcji płciowej, choć kobiety częściej zgłaszają problem lekarzom. Najczęściej rozpoczyna się w dzieciństwie lub okresie dojrzewania, z największą częstością w grupie wiekowej 18-39 lat (8,8%). Hiperhidroza pierwotna, stanowiąca ponad 90% przypadków, ma silne podłoże genetyczne (do 66% pacjentów z rodzinnym występowaniem), często jest wieloogniskowa i dotyczy głównie pach (68%), dłoni (65%) i stóp (64%). Występują istotne różnice geograficzne i etniczne, np. hiperhidroza dłoniowo-podeszwowa jest 20-krotnie częstsza u Japończyków. Hiperhidroza wtórna stanowi mniejszość przypadków i jest związana z innymi schorzeniami lub lekami.
- Epidemiologia nadmiernej potliwości (hiperhidrozy)
- Częstotliwość występowania hiperhidrozy na świecie
- Różnice geograficzne i etniczne
- Rozkład według płci i wieku
- Predyspozycje genetyczne
- Hiperhidroza pierwotna vs. wtórna
- Obszary dotykane nadmierną potliwością
- Wpływ na jakość życia
- Trendy epidemiologiczne i rozpoznawanie choroby
- Powikłania i choroby współistniejące
- Implikacje ekonomiczne
- Nadzór i monitorowanie hiperhidrozy
Epidemiologia nadmiernej potliwości (hiperhidrozy)
Nadmierna potliwość (hiperhidroza) to stan patologiczny charakteryzujący się nadmiernym wydzielaniem potu, wykraczającym poza potrzeby fizjologiczne związane z termoregulacją organizmu. Epidemiologia tego schorzenia była przez długi czas słabo udokumentowana, jednak w ciągu ostatnich dwóch dekad nastąpił znaczący wzrost liczby badań dostarczających informacji na temat rozpowszechnienia hiperhidrozy na całym świecie.12
Częstotliwość występowania hiperhidrozy na świecie
Dane epidemiologiczne dotyczące hiperhidrozy wykazują znaczne zróżnicowanie w zależności od regionu geograficznego, metodologii badania oraz populacji objętej badaniem. Ogólnoświatowe szacunki wskazują, że hiperhidroza dotyka od 2% do 4% populacji, bez wyraźnej predylekcji płciowej.1 Jednakże nowsze badania sugerują, że rzeczywista częstość występowania może być wyższa:
- W Stanach Zjednoczonych rozpowszechnienie hiperhidrozy szacuje się na 2,8-4,8% populacji, co przekłada się na około 7,8-15,3 miliona Amerykanów23
- W Szwecji częstość występowania pierwotnej hiperhidrozy ocenia się na 5,5%, z czego ciężka hiperhidroza pierwotna dotyka 1,4% populacji45
- W Chinach, wśród pacjentów dermatologicznych w Szanghaju, odnotowano częstość występowania na poziomie 14,5%6
- W Japonii rozpowszechnienie hiperhidrozy pachowej wśród pracowników i studentów sięga 5,75%7
- W Brazylii, badanie przeprowadzone w mieście Botucatu wykazało, że 2,07% mieszkańców zgłasza nadmierną potliwość, jednak po dokładnej ocenie medycznej rzeczywista częstość pierwotnej hiperhidrozy wyniosła 0,93%8
- W Danii, badanie przeprowadzone wśród dawców krwi wykazało, że 9,07% respondentów zgłaszało umiarkowaną do ciężkiej hiperhidrozę, podczas gdy 0,23% miało hiperhidrozę zdiagnozowaną w szpitalu9
Te znaczące różnice w danych epidemiologicznych mogą wynikać z różnych metod badawczych, kryteriów diagnostycznych oraz różnic kulturowych w postrzeganiu i zgłaszaniu nadmiernej potliwości.10 Warto zauważyć, że częstość występowania hiperhidrozy samodzielnie zgłaszanej przez pacjentów jest zazwyczaj wyższa niż potwierdzona diagnoza medyczna.11
Różnice geograficzne i etniczne
Badania epidemiologiczne wskazują na pewne różnice geograficzne i etniczne w częstości występowania hiperhidrozy:
- Hiperhidroza dłoniowo-podeszwowa występuje 20 razy częściej u Japończyków niż w innych grupach etnicznych1
- Wśród Amerykanów pochodzenia japońskiego obserwuje się większą częstość występowania hiperhidrozy dłoni i stóp2
- Rozpowszechnienie choroby w Chinach w niektórych regionach sięga 5,0%, co jest wyższe niż średnia światowa3
Te różnice mogą sugerować wpływ czynników genetycznych i środowiskowych na rozwój hiperhidrozy.4
Rozkład według płci i wieku
Hiperhidroza dotyka zarówno mężczyzn, jak i kobiety, bez wyraźnej predylekcji płciowej, choć niektóre badania wskazują na niewielkie różnice:
- W badaniach przeprowadzonych w Stanach Zjednoczonych i Wielkiej Brytanii około 60% zarejestrowanych przypadków hiperhidrozy stanowiły kobiety12
- Kobiety częściej zgłaszają hiperhidrozę lekarzowi, co może wpływać na statystyki34
- U mężczyzn częściej występuje hiperhidroza w obszarze twarzy i głowy, podczas gdy u kobiet częściej dotyczy ona pach5
Jeśli chodzi o wiek, hiperhidroza pierwotna ma charakterystyczny wzorzec występowania:
- Najczęściej rozpoczyna się w dzieciństwie lub okresie dojrzewania12
- W badaniu obejmującym 850 pacjentów z hiperhidrozą dłoni, pach lub twarzy, 62% pacjentów zgłosiło, że nadmierna potliwość rozpoczęła się „odkąd pamiętają”, 33% od okresu dojrzewania, a 5% w wieku dorosłym3
- Największą częstość występowania obserwuje się w grupie wiekowej 18-39 lat (8,8%)4
- Częstość występowania jest niższa wśród osób powyżej 65 roku życia, co może wynikać z regresji choroby z upływem czasu5
- Wśród nastolatków, według jednego z badań, 17,1% doświadcza nadmiernej, niekontrolowanej potliwości6
Warto również zauważyć korelację między lokalizacją nadmiernej potliwości a wiekiem pacjentów – młodzież i młodzi dorośli częściej doświadczają hiperhidrozy dłoni, podczas gdy u dorosłych częściej występuje w okolicach pach.7
Predyspozycje genetyczne
Istnieją silne dowody wskazujące na genetyczne podłoże pierwotnej hiperhidrozy:
- Do 66% pacjentów z hiperhidrozą pierwotną zgłasza występowanie podobnych objawów u członków najbliższej rodziny1
- Najnowsze dane (2018) wskazują, że 18% osób cierpiących na hiperhidrozę zgłasza, że bezpośredni członek rodziny również cierpi na nadmierną potliwość23
- Serie badań na pacjentach leczonych za pomocą endoskopowej sympatektomii piersiowej (ETS) wykazały występowanie hiperhidrozy w rodzinie u 35% do 56% uczestników45
- W duńskim badaniu wykazano, że hiperhidroza samoistna była silnie związana z potencjalnymi czynnikami ryzyka genetycznego6
- W 2006 roku badacze z Uniwersytetu Saga w Japonii stwierdzili, że pierwotna hiperhidroza dłoni jest mapowana do locus genu 14q11.2-q137
Te odkrycia sugerują, że hiperhidroza pierwotna może być dziedziczona jako cecha autosomalnie dominująca z niepełną penetracją genu.8
Hiperhidroza pierwotna vs. wtórna
W epidemiologii hiperhidrozy istotne jest rozróżnienie między hiperhidrozą pierwotną (idiopatyczną) a wtórną:
- Ponad 90% przypadków hiperhidrozy to hiperhidroza pierwotna1
- Hiperhidroza pierwotna zwykle dotyka określonych obszarów ciała (ogniskowa) i nie ma identyfikowalnej przyczyny medycznej2
- Hiperhidroza wtórna stanowi mniejszość przypadków i jest spowodowana innymi schorzeniami lub przyjmowanymi lekami3
- W badaniu przeprowadzonym w Szwecji hiperhidroza wtórna występowała u 14,8% uczestników badania4
Obszary dotykane nadmierną potliwością
Hiperhidroza pierwotna najczęściej dotyczy określonych obszarów ciała:
- Według badania z 2016 roku, obejmującego 1985 uczestników, hiperhidroza pachowa była najbardziej powszechnym typem hiperhidrozy (68%), następnie dłoniowa (65%) i stóp (64%)1
- Ponad połowa przypadków hiperhidrozy pierwotnej dotyczy pach2
- Region dłoni jest najczęściej dotkniętym obszarem w ogólnej populacji pacjentów z hiperhidrozą3
- Dane pokazują, że wieloogniskowa hiperhidroza jest powszechna, przy czym 81% pacjentów zgłasza trzy lub więcej miejsc nadmiernej potliwości45
Warto podkreślić, że pierwotna hiperhidroza ogniskowa jest najczęściej chorobą wieloogniskową, co oznacza, że dotyka wielu obszarów ciała jednocześnie.67
Wpływ na jakość życia
Hiperhidroza ma znaczący wpływ na jakość życia osób dotkniętych tym schorzeniem:
- Wśród 23 osób zdiagnozowanych z pierwotną hiperhidrozą w badaniu brazylijskim, 11 (48%) zgłosiło słabą lub bardzo słabą jakość życia1
- Ponad jedna trzecia osób z hiperhidrozą pachową zgłasza, że stan ten jest ledwo tolerowany lub całkowicie nietolerowany i prawie zawsze zakłóca codzienne czynności2
- Badanie przeprowadzone wśród studentów medycyny w Rio de Janeiro wykazało, że 86,84% uczestników z hiperhidrozą pierwotną zgłosiło pewien stopień wpływu na jakość życia3
- Hiperhidroza negatywnie wpływa na dobrostan emocjonalny, samoocenę, relacje międzyludzkie i wydajność zawodową4
Te dane podkreślają, że hiperhidroza nie jest jedynie problemem kosmetycznym, ale schorzeniem mającym istotny wpływ na wszystkie aspekty życia pacjenta.5
Trendy epidemiologiczne i rozpoznawanie choroby
Badania epidemiologiczne ujawniają istotne trendy dotyczące rozpoznawania i leczenia hiperhidrozy:
- 85% pacjentów czeka ponad 3 lata przed omówieniem nadmiernej potliwości z pracownikiem służby zdrowia, a 50% czeka ponad 10 lat1
- 27% pacjentów nigdy nie otrzymuje diagnozy2
- Mniej niż połowa osób dotkniętych hiperhidrozą omawia ten problem ze swoim lekarzem3
- Badanie z 2016 roku wykazało, że hiperhidroza jest często problemem trwającym przez całe życie, przy czym nasilenie objawów NIE zmniejsza się z wiekiem – 88% pacjentów zgłosiło, że objawy pogorszyły się lub pozostały bez zmian w miarę upływu czasu45
Dane te wskazują, że hiperhidroza jest często niedodiagnozowana i nieleczona, co podkreśla potrzebę zwiększenia świadomości zarówno wśród pacjentów, jak i pracowników służby zdrowia.67
Powikłania i choroby współistniejące
Hiperhidroza może prowadzić do różnych powikłań i jest związana z pewnymi chorobami współistniejącymi:
- Osoby z hiperhidrozą są bardziej narażone na infekcje skórne – według Międzynarodowego Towarzystwa Hiperhidrozy (IHHS), osoby te mają o 300% większe ryzyko infekcji skórnych w porównaniu z osobami bez tej choroby1
- Hiperhidroza ma bezpośredni wpływ na stan skóry poprzez zakłócanie jej naturalnych mechanizmów ochronnych, co skutkuje większą częstością występowania dermatoz, szczególnie o pochodzeniu grzybiczym, bakteryjnym i rzadziej wirusowym2
- W badaniu duńskim samoistna hiperhidroza była związana z potencjalnymi czynnikami ryzyka (palenie tytoniu, nadwaga) oraz potencjalnymi implikacjami choroby (bezrobocie, niski poziom wykształcenia i dochodu)34
- Niedawne badanie sugeruje, że osoby z atopowym zapaleniem skóry doświadczają zmian w aktywacji nerwowej gruczołów potowych i wyższej częstości hiperhidrozy5
- Hiperhidroza jest częstym działaniem niepożądanym leków przeciwdepresyjnych i może prowadzić do przerwania leczenia6
Implikacje ekonomiczne
Hiperhidroza generuje znaczące obciążenie ekonomiczne:
- Według raportu IMARC Group, siedem głównych rynków hiperhidrozy (7MM) osiągnęło wartość 426,7 miliona dolarów w 2023 roku i przewiduje się, że do 2034 roku osiągnie 651,2 miliona dolarów, przy rocznym wskaźniku wzrostu (CAGR) 3,92% w latach 2024-20341
- Stany Zjednoczone mają największą grupę pacjentów z hiperhidrozą i reprezentują największy rynek jej leczenia2
- Koszty hospitalizacji stanowią największe obciążenie ekonomiczne w zakresie kosztów bezpośrednich3
- Pacjenci ponoszą koszty związane z próbami radzenia sobie z nadmierną potliwością i jej ukrywaniem4
Nadzór i monitorowanie hiperhidrozy
Systematyczny nadzór i monitorowanie występowania hiperhidrozy są kluczowe dla lepszego zrozumienia epidemiologii tej choroby oraz opracowania skutecznych strategii leczenia.12
Metody oceny i diagnozy
Różnorodność metod oceny i diagnozy hiperhidrozy wpływa na zmienność danych epidemiologicznych:
- Panel ekspertów zaproponował następujące kryteria diagnostyczne dla pierwotnej hiperhidrozy ogniskowej: ogniskowe, widoczne, nadmierne pocenie się trwające co najmniej sześć miesięcy bez widocznej przyczyny1
- Skala Nasilenia Choroby Hiperhidrozy (HDSS) to zwalidowane jednoelementowe badanie z czterema stopniami tolerancji pocenia się i wpływu na jakość życia, które może oszacować wpływ na codzienne czynności i odpowiedź na leczenie2
- Badania epidemiologiczne często wykorzystują kwestionariusze samooceny, które mogą prowadzić do wyższych wskaźników zgłaszanej hiperhidrozy w porównaniu z diagnozą kliniczną3
- W badaniu brazylijskim, po ocenie medycznej, 25% pacjentów, którzy zgłosili nadmierną potliwość, wykazywało normalne pocenie się, a 30% miało hiperhidrozę wtórną. W rezultacie ponad połowa osób zgłaszających nadmierną potliwość nie miała faktycznie hiperhidrozy pierwotnej4
Te różnice w metodach oceny podkreślają potrzebę standaryzacji diagnozowania hiperhidrozy w celu uzyskania bardziej dokładnych danych epidemiologicznych.5
Zalecenia dotyczące monitorowania
Aby poprawić nadzór epidemiologiczny nad hiperhidrozą, eksperci zalecają:
- Wdrożenie programów edukacyjnych dla lekarzy, specjalistów medycznych i pacjentów w celu zwiększenia świadomości na temat tego schorzenia1
- Prowadzenie dalszych badań o szerszym zakresie i większych populacjach pacjentów2
- Generowanie większej ilości danych dla regionów o ograniczonych informacjach epidemiologicznych3
- Ulepszenie praktyk identyfikowania hiperhidrozy w warunkach klinicznych, co może zwiększyć czułość i swoistość przyszłych badań oraz poprawić charakterystykę i kwantyfikację obciążenia populacji tą istotną chorobą4
- Wcześniejsza interwencja i wsparcie mogą mieć istotny wpływ na radzenie sobie z wyzwaniami związanymi z życiem z pierwotną hiperhidrozą5
Wyzwania w monitorowaniu hiperhidrozy
Istnieje kilka znaczących wyzwań w monitorowaniu epidemiologii hiperhidrozy:
- Brak świadomości hiperhidrozy w społeczeństwie, stygmatyzacja związana z nadmiernym poceniem się i szukaniem pomocy z powodu pocenia się, oraz przekonanie, że leczenie jest bezcelowe, prowadzą do tego, że większość dorosłych z hiperhidrozą nie szuka pomocy medycznej1
- Brak świadomości diagnostyki i metod leczenia hiperhidrozy wśród lekarzy oraz pozornie łagodna symptomatologia hiperhidrozy prowadzą do tego, że wielu pacjentów szukających pomocy z powodu hiperhidrozy nie otrzymuje odpowiedniego leczenia lub nie jest kierowanych do dermatologów2
- Brak jest wytycznych określających, co dokładnie stanowi normalne pocenie się, co utrudnia określenie rzeczywistej częstości występowania hiperhidrozy3
- Hiperhidroza jest często niedodiagnozowana i nieleczona, co może prowadzić do niedoszacowania rzeczywistego rozpowszechnienia4
Podsumowując, epidemiologia nadmiernej potliwości (hiperhidrozy) charakteryzuje się znacznym zróżnicowaniem w zależności od regionu geograficznego, metod badawczych i populacji. Globalne dane wskazują na rozpowszechnienie od 2% do 4%, ale nowsze badania sugerują, że rzeczywiste wartości mogą być wyższe, sięgając 4,8% w USA. Choroba dotyka zarówno mężczyzn, jak i kobiety, najczęściej rozpoczyna się w dzieciństwie lub okresie dojrzewania i wykazuje silny komponent genetyczny. Hiperhidroza ma znaczący wpływ na jakość życia pacjentów i generuje istotne obciążenie ekonomiczne. Wyzwania w monitorowaniu i diagnozowaniu hiperhidrozy podkreślają potrzebę standaryzacji metod oceny oraz zwiększenia świadomości wśród pacjentów i pracowników służby zdrowia.56
| Region | Częstość występowania hiperhidrozy | Rodzaj badania/populacji | Uwagi |
|---|---|---|---|
| Stany Zjednoczone | 2,8-4,8% | Populacja ogólna | Około 7,8-15,3 miliona osób |
| Szwecja | 5,5% | Populacja ogólna | 1,4% z ciężką hiperhidrozą pierwotną |
| Chiny (Szanghaj) | 14,5% | Pacjenci dermatologiczni | Wyższe niż w populacji ogólnej |
| Kanada (Vancouver) | 12,3% | Pacjenci dermatologiczni | Wyższe niż w populacji ogólnej |
| Japonia | 5,75% | Pracownicy i studenci | Specyficznie dla hiperhidrozy pachowej |
| Brazylia (Botucatu) | 2,07% (zgłaszana) 0,93% (potwierdzona) |
Populacja ogólna | Znacząca różnica między samoocenioną a zdiagnozowaną |
| Dania | 9,07% (samoraportowana) 0,23% (szpitalnie zdiagnozowana) |
Dawcy krwi | Duża rozbieżność między samooceną a diagnozą kliniczną |
| Polska | 8,0% | Studenci medycyny i stomatologii | Badanie Stefaniaka i wsp. |
| Indie | 2,5-3% | Populacja ogólna | Zgodne z globalnym szacunkiem |
| Wielka Brytania | 0,13% (zachorowalność) | Dane z opieki zdrowotnej | Niższa wartość związana z metodologią |
Kolejne rozdziały
Zapraszamy do dalszego czytania naszego leksykonu.
Wybierz kolejny rozdział z menu poniżej, aby otworzyć nową podstronę kompedium wiedzy i uzyskać szczegółowe informację o leku, substancji lub chorobie.
Materiały źródłowe
- #1 Hyperhidrosis prevalence and its impact on population – Hasimoto – Shanghai Chesthttps://shc.amegroups.org/article/view/5114/html
Hyperhidrosis is a disorder characterized by excessive sweating which beyond the physiological need for body thermoregulation. The prevalence data available in the literature are practically nonexistent up to the beginning of the 21st century. The prevalence found in the articles varied from 0.072% to 16.3%. As to the impact on the quality of life, all articles have shown that such disorder affects in some way the life of the individuals. The data available in the literature regarding the prevalence of hyperhidrosis in the world population are practically nonexistent until the beginning of the 21st century, therefore up to some time ago little was known about the number of individuals bearing this disorder. The bibliographic review was done by using the PubMed database (until January 10th 2019). Sixteen articles that evaluated the prevalence of hyperhidrosis were found in the research, 15 of them were published from the 21st century. The prevalence of hyperhidrosis found in the articles ranged from 0.072% to 16.3%. The first citation found in the literature about the prevalence of hyperhidrosis is from 1977. The first published work with methodological description was the one by Strutton et al. in 2004. In 2007 China published two studies about the prevalence of hyperhidrosis. The lowest prevalence of published hyperhidrosis was 0.072%, by Chu et al. The highest prevalence published among all published papers was the one by Augustin et al. in 2013. The most recent work about the prevalence of hyperhidrosis belongs to our group, published in 2018. The existing data of hyperhidrosis prevalence in the world population are well varied and questionable due to the heterogeneity of methodologies used in several studies. The impacts of hyperhidrosis in the quality of life of the individuals are well known in daily practice and are confirmed by means of the applied questionnaires aimed at measuring the severity and the interference of the disorder in the daily life of its patient.
- #1 Azthena logo with the word Azthenahttps://www.news-medical.net/health/Hyperhidrosis-Prognosis-and-Epidemiology.aspx
Hyperhidrosis refers to excessive sweating that does not necessarily occur in response to the body becoming overheated by exercise or a hot environment, for example. […] It is difficult to say how many people develop hyperhidrosis as there are no guidelines to determine exactly what constitutes normal sweating, but estimates suggest that the worldwide prevalence is between 2% and 4%, without any particular gender predisposition. […] There are differences in prevalence globally, with one study, for example, having shown a prevalence of 2.9% in the US and up to 5.0% prevalence in certain areas of China.
- #1 Hyperhidrosis: Background, Pathophysiology, Etiologyhttps://emedicine.medscape.com/article/1073359-overview
In the United States and the United Kingdom, 1-1.6% of people have records reflecting hyperhidrosis. About 60% in both databases were women. […] In adolescents and young adults, an incidence rate of 0.6-1% is reported for hyperhidrosis. […] Palmoplantar hyperhidrosis occurs 20 times more frequently in the Japanese than in any other ethnic group. […] All races can be affected by hyperhidrosis; however, Japanese are reportedly affected more than 20 times more frequently than other ethnic groups. […] Both sexes can be affected by hyperhidrosis. […] Persons of all ages can be affected by hyperhidrosis. Localized hyperhidrosis, unlike generalized hyperhidrosis, usually begins in childhood or adolescence. In a study of 850 patients with palmar, axillary, or facial hyperhidrosis, 62% of patients reported that sweating began since before they could remember; 33%, since puberty; and 5%, during adulthood.
- #1 Epidemiology of Primary Hyperhidrosis – International Hyperhidrosis Society | Official Sitehttps://www.sweathelp.org/about-hyperhidrosis/epidemiology-of-primary-hyperhidrosis.html
Results showed that the prevalence of hyperhidrosis in the U.S. was 2.8% (7.8 million Americans). […] Recent data (2018) found that 18% of Hh sufferers report an immediate family member also suffering from excessive sweating. […] A series of studies on patients treated by endoscopic thoracic sympathectomy (ETS) reported a family history in 35% and 56% of participants. […] A study of the familial aggregation of hyperhidrosis also suggested that the disorder may be more common than previously thought. […] Focal primary hyperhidrosis has an onset during childhood or adolescence. […] This 2016 study also showed that hyperhidrosis is often a lifelong struggle with symptom severity FAILING to lessen with age — 88% reported that symptoms have become worse or stayed the same over time. […] In 2016, results from 1,985 survey participants showed that axillary hyperhidrosis was the most prevalent type of hyperhidrosis in the study sample (68%) followed by palmar (65%) and plantar (64%). […] It should be noted here, again, the primary focal Hh is most typically a multifocal disease. […] Key take-aways: primary Hh is relatively common, multifocal, and chronic with an onset in youth and an apparent genetic link — yet, diagnosis and treatment is often delayed for years.
- #1 Pathophysiology of hyperhidrosis – Choe – Shanghai Chesthttps://shc.amegroups.org/article/view/5204/html
Primary hyperhidrosis is a pathologic condition that is characterized by excessive sweating beyond the physiological needs required for thermoregulation. It affects 0.65% of the world population and inflicts a significant impact on the quality of life in affected patients. […] Primary hyperhidrosis affects 0.65% of the world population and affects men and women equally. […] The exact pathophysiology of hyperhidrosis remains largely unclear. Most epidemiological studies have shown the existence of a familial trait for primary hyperhidrosis, as 44% to 66% of patients share a positive family history. […] A recent systematic review on the etiology of primary hyperhidrosis by Hashmonai et al. describe three main lines for future research, in order to delineate the pathophysiology of primary hyperhidrosis: genetics, histological observations and enzymatic studies. […] Primary hyperhidrosis is a neurogenic disorder that is characterized by excessive sweating in certain areas of the body, including axillae and palmar surfaces of hands and feet, resulting from an increased activity of sympathetic cholinergic sudomotor nerves.
- #1 Hyperhidrosis: Management Options | AAFPhttps://www.aafp.org/pubs/afp/issues/2018/0601/p729.html
Hyperhidrosis affects 1% to 3% of the U.S. population, yet less than one-half of those affected discuss this with their physician. More than 90% of hyperhidrosis cases are primary, and more than one-half of these cases affect the axillae. More than one-third of persons with axillary hyperhidrosis report that the condition is barely tolerable or completely intolerable, and it nearly always interferes with daily activities. Up to two-thirds of patients report a family history, suggesting a genetic predisposition. Although prevalence between sexes is roughly equal, women are more likely to report hyperhidrosis to their physician. […] Hyperhidrosis negatively impacts daily life, especially emotional well-being, self-esteem, interpersonal relationships, and occupational productivity. Although several tools have been developed to measure the impact of hyperhidrosis on quality of life, most are too complex to incorporate into office practice. The Hyperhidrosis Disease Severity Scale (HDSS) is a validated single-question survey with four grades of tolerability of sweating and impact on quality of life. This survey can estimate the effect on daily activities and response to treatment.
- #1https://pmc.ncbi.nlm.nih.gov/articles/PMC6326708/
To determine the prevalence of primary hyperhidrosis in the city of Botucatu, Brazil, and to evaluate how this disorder affects the quality of life in those suffering from it. […] Excessive sweating was reported by 85 residents (prevalence = 2.07%), of whom 51 (60%) were female. […] Of the 23 subjects diagnosed with primary hyperhidrosis, 11 (48%) reported poor or very poor quality of life. […] Although the prevalence of self-reported excessive sweating was greater than 2%, the actual prevalence of primary hyperhidrosis in our sample was 0.93% and nearly 50% of the respondents with primary hyperhidrosis reported impaired quality of life. […] Data on the prevalence of hyperhidrosis are quite scarce in the medical literature. […] In our study, the prevalence of hyperhidrosis after the application of a questionnaire by trained interviewers was above 2%, as observed by Strutton et al. […] Therefore, after medical evaluation, the estimated prevalence of PH decreased to less than 1%. […] We conclude that the estimated prevalence of PH is near 1%, small in comparison with the number of subjects who report excessive sweating. The disorder affects the QoL in nearly 50% of subjects.
- #1 Epidemiology of Primary Hyperhidrosis – Focus on Hyperhidrosishttps://www.medpagetoday.com/resource-centers/focus-hyperhidrosis/epidemiology-primary-hyperhidrosis/2281
Data showed that multifocal hyperhidrosis is common with 81% of patients reporting three or more hyperhidrotic sites. […] Data presented as an abstract on „pediatric breaking news” showed that 17.1% of teens surveyed experience excessive, uncontrollable sweating based on published diagnostic criteria. […] Hyperhidrosis (extreme, uncontrollable sweating affecting 4.8% of people) is often misunderstood, misrepresented and mismanaged, but for the past 15 years the International Hyperhidrosis Society has been bringing the full range of stakeholders to the table to transform missed opportunities into an impactful mission. […] 85% waiting 3+ years to discuss excessive sweating with an HCP and 50% waiting 10+ years to do so. […] 27% never receiving diagnosis. […] Recent data (2018) found that 18% of Hh sufferers report an immediate family member also suffering from excessive sweating.
- #1 Hyperhidrosis and Its Impact on Those Living With Ithttps://www.ajmc.com/view/hyperhidrosis-and-its-impact–on-those-living-with-it
Some literature suggests a possible racial difference in the prevalence of primary hyperhidrosis, with more Japanese American patients affected by hyperhidrosis in the palms and soles. […] Hyperhidrosis negatively affects QOL and, as such, numerous QOL assessment tools are used to evaluate the condition. […] To date, many QOL impact studies have been completed outside of the United States, but it is likely the results represent QOL in US patients. […] The International Hyperhidrosis Society (IHHS) reports that those with hyperhidrosis have a 300% greater risk of skin infections than those not experiencing the disease. […] Approximately 15.3 million Americans are impacted by hyperhidrosis. […] Hyperhidrosis impairs emotional, mental, and professional facets of living, leading to a significantly decreased QOL. […] It is imperative that healthcare practitioners understand the epidemiology and impact this disease has on individuals.
- #1 Hyperhidrosis Market Size, Share | Industry Forecast, 2034https://www.imarcgroup.com/hyperhidrosis-market
The 7 major hyperhidrosis markets reached a value of US$ 426.7 Million in 2023. Looking forward, IMARC Group expects the 7MM to reach US$ 651.2 Million by 2034, exhibiting a growth rate (CAGR) of 3.92% during 2024-2034. […] Hyperhidrosis affects at least 176 million people globally. […] The prevalence of hyperhidrosis is approximately 15.3 million people in the US population. […] The prevalence rate is 2.1% among children and adolescents and people 65 years of age and beyond, with the largest rates occurring in the 18-39 age group (8.8%). […] In India, hyperhidrosis affects about 2.5-3 percent of the population.
- #1 Hyperhidrosis Limits Patientsâ Daily Functioning, Quality of Life Across Several Different Regionshttps://www.consultantlive.com/view/hyperhidrosis-limits-patients-daily-functioning-quality-of-life-across-several-different-regions
In this recent analysis of hyperhidrosis burden on patients, prevalence of the condition and its impacts on patients demonstrate the value of exploring knowledge gaps for this disease. […] The disease known as hyperhidrosis a chronic skin condition known to cause excessive sweating can result in significant psychological, physical, and economic burden for patients daily lives across several different regions, according to new findings, and its prevalence varies substantially across different populations. […] Little is known about the epidemiology and burden of hyperhidrosis across regions to date, Ikoma and colleagues wrote. Therefore, the objective of the project was to gather current evidence on the burden of hyperhidrosis by conducting targeted literature reviews (TLR) on epidemiology, and the human and economic burden posed on patients with this condition.
- #1 Primary focal hyperhidrosis – UpToDatehttps://www.uptodate.com/contents/primary-focal-hyperhidrosis
Hyperhidrosis (excessive sweating) is a common condition rarely due to significant underlying pathology that may have serious social, emotional, and professional consequences. […] Hyperhidrosis is the secretion of sweat in amounts greater than physiologically needed for thermoregulation. It is most commonly a chronic idiopathic (primary) condition; however, secondary medical conditions or medications should be excluded. Idiopathic hyperhidrosis localized to certain areas of the body is called primary focal hyperhidrosis. Primary focal hyperhidrosis usually affects the axillae, palms, and soles. The condition may also affect other sites, such as the face, scalp, inguinal, and inframammary areas. […] A consensus panel suggested the following diagnostic criteria for primary focal hyperhidrosis: Focal, visible, excessive sweating of at least six months duration without apparent cause.
- #1 Hyperhidrosis Disease Burden Requires Further Understandinghttps://www.dermatologytimes.com/view/hyperhidrosis-disease-burden-requires-further-understanding
The cost of hospitalizations was found to be the highest in terms of economic burden of direct costs. […] Future actions should include implementation of educational programs for physicians, medical specialists, and patients to raise awareness of the condition; the conduct of further studies with larger scope and bigger patient populations; and the generation of more evidence for Japan, concluded the authors.
- #1 Epidemiology of Hyperhidrosis in Danish Blood Donors | HTML | Acta Dermato-Venereologicahttps://www.medicaljournals.se/acta/content/html/10.2340/00015555-3790
This retrospective cohort study found that the prevalence of self-reported HH in blood donors was in line with previous reports. The prevalence of hospital-diagnosed HH was lower than previously reported. This may be the result of selection bias, as blood donors are implicitly healthy and have fewer diagnoses than the general population, or that individuals with hospital-diagnosed HH were receiving medications that precluded blood donation and thus study participation. […] We speculate that several factors contribute to the differences in prevalence, lifestyle habits, SES and income between self-reported and hospital-diagnosed HH. Firstly, low awareness of HH in the public, the stigma surrounding excessive sweating and seeking help for sweating, and the notion that treatments are futile lead to most adults with HH not seeking medical help for sweating. Next, lack of awareness of diagnostics and treatments for HH in physicians, and the seemingly benign symptomatology of HH, lead to many who seek help for HH not being given adequate treatment or referred to dermatologists.
- #2 SciELO Brasil – Hyperhidrosis: prevalence and impact on quality of life Hyperhidrosis: prevalence and impact on quality of lifehttps://www.scielo.br/j/jbpneu/a/gxS3VxQSW3j7hX5MkLXDxqz/
Objective: To determine the prevalence of primary hyperhidrosis in the city of Botucatu, Brazil, and to evaluate how this disorder affects the quality of life in those suffering from it. […] A total of 4,133 residents, in 1,351 households, were surveyed. Excessive sweating was reported by 85 residents (prevalence = 2.07%), of whom 51 (60%) were female. […] Although the prevalence of self-reported excessive sweating was greater than 2%, the actual prevalence of primary hyperhidrosis in our sample was 0.93% and nearly 50% of the respondents with primary hyperhidrosis reported impaired quality of life. […] There are few data on the worldwide prevalence of hyperhidrosis, reported values ranging from 0.072% to 9%. […] In our study, the prevalence of hyperhidrosis after the application of a questionnaire by trained interviewers was above 2%, as observed by Strutton et al. However, after medical evaluation, 25% of the patients that reported excessive sweating actually showed normal sweating and 30% had SH. Consequently, more than half of the subjects that reported excessive sweating did not actually have PH. Therefore, after medical evaluation, the estimated prevalence of PH decreased to less than 1%.
- #2 Epidemiology of Primary Hyperhidrosis – International Hyperhidrosis Society | Official Sitehttps://www.sweathelp.org/about-hyperhidrosis/epidemiology-of-primary-hyperhidrosis.html
In the past, there was little data on the prevalence of primary hyperhidrosis (Hh). Recently, however, more studies have been published in the medical literature – with illuminating statistics: […] Researchers reported the prevalence of hyperhidrosis in the United States as 4.8%, representing approximately 15.3 million people. […] A study showed that, in Sweden, prevalence of primary hyperhidrosis was 5.5% with severe, primary hyperhidrosis affecting 1.4% of the population. […] Research results found that the prevalence of primary hyperhidrosis among dermatology outpatients in Shanghai was 14.5% and in Vancouver was 12.3%. […] Data showed that multifocal hyperhidrosis is common with 81% of patients reporting three or more hyperhidrotic sites. […] Data presented as an abstract on „pediatric breaking news” showed that 17.1% of teens surveyed experience excessive, uncontrollable sweating based on published diagnostic criteria.
- #2 Hyperhidrosis and Its Impact on Those Living With Ithttps://www.ajmc.com/view/hyperhidrosis-and-its-impact–on-those-living-with-it
Some literature suggests a possible racial difference in the prevalence of primary hyperhidrosis, with more Japanese American patients affected by hyperhidrosis in the palms and soles. […] Hyperhidrosis negatively affects QOL and, as such, numerous QOL assessment tools are used to evaluate the condition. […] To date, many QOL impact studies have been completed outside of the United States, but it is likely the results represent QOL in US patients. […] The International Hyperhidrosis Society (IHHS) reports that those with hyperhidrosis have a 300% greater risk of skin infections than those not experiencing the disease. […] Approximately 15.3 million Americans are impacted by hyperhidrosis. […] Hyperhidrosis impairs emotional, mental, and professional facets of living, leading to a significantly decreased QOL. […] It is imperative that healthcare practitioners understand the epidemiology and impact this disease has on individuals.
- #2 Epidemiology of hyperhidrosis in 2 population-based health care databases – EM consultehttps://www.em-consulte.com/es/article/1193840/resume/epidemiology-of-hyperhidrosis-in-2-population-base
Epidemiology of hyperhidrosis in 2 population-based health care databases – 13/01/18 […] Population-based and clinical case reports of hyperhidrosis (HH) provide prevalence estimates that vary widely across reported studies because of differences in case ascertainment. […] In this study, we specify diagnostic, symptom, and prescription codes for HH to estimate incidence and prevalence for the United Kingdom and the United States. […] Data from UK and US health care databases were analyzed to ascertain HH cases and estimate incidence and prevalence from health care records during calendar years 2011 through 2013. […] On the basis of 2013 data for the United States and United Kingdom, between 1.0% and 1.6% of these populations have health care records indicating diagnosis or treatment of HH. Women accounted for approximately 60% of incident and prevalent cases in both databases. […] The findings represent a plausible estimate for incidence and prevalence of HH among persons seeking medical care for excessive sweating. Improved practices for identifying HH in clinical settings may increase the sensitivity and specificity of future studies and improve characterization and quantification of the population burden of this significant disease.
- #2 Hyperhidrosis: Background, Pathophysiology, Etiologyhttps://emedicine.medscape.com/article/1073359-overview
In the United States and the United Kingdom, 1-1.6% of people have records reflecting hyperhidrosis. About 60% in both databases were women. […] In adolescents and young adults, an incidence rate of 0.6-1% is reported for hyperhidrosis. […] Palmoplantar hyperhidrosis occurs 20 times more frequently in the Japanese than in any other ethnic group. […] All races can be affected by hyperhidrosis; however, Japanese are reportedly affected more than 20 times more frequently than other ethnic groups. […] Both sexes can be affected by hyperhidrosis. […] Persons of all ages can be affected by hyperhidrosis. Localized hyperhidrosis, unlike generalized hyperhidrosis, usually begins in childhood or adolescence. In a study of 850 patients with palmar, axillary, or facial hyperhidrosis, 62% of patients reported that sweating began since before they could remember; 33%, since puberty; and 5%, during adulthood.
- #2 Epidemiology of Primary Hyperhidrosis – International Hyperhidrosis Society | Official Sitehttps://www.sweathelp.org/about-hyperhidrosis/epidemiology-of-primary-hyperhidrosis.html
Results showed that the prevalence of hyperhidrosis in the U.S. was 2.8% (7.8 million Americans). […] Recent data (2018) found that 18% of Hh sufferers report an immediate family member also suffering from excessive sweating. […] A series of studies on patients treated by endoscopic thoracic sympathectomy (ETS) reported a family history in 35% and 56% of participants. […] A study of the familial aggregation of hyperhidrosis also suggested that the disorder may be more common than previously thought. […] Focal primary hyperhidrosis has an onset during childhood or adolescence. […] This 2016 study also showed that hyperhidrosis is often a lifelong struggle with symptom severity FAILING to lessen with age — 88% reported that symptoms have become worse or stayed the same over time. […] In 2016, results from 1,985 survey participants showed that axillary hyperhidrosis was the most prevalent type of hyperhidrosis in the study sample (68%) followed by palmar (65%) and plantar (64%). […] It should be noted here, again, the primary focal Hh is most typically a multifocal disease. […] Key take-aways: primary Hh is relatively common, multifocal, and chronic with an onset in youth and an apparent genetic link — yet, diagnosis and treatment is often delayed for years.
- #2 Primary focal hyperhidrosis – UpToDatehttps://www.uptodate.com/contents/primary-focal-hyperhidrosis
Hyperhidrosis (excessive sweating) is a common condition rarely due to significant underlying pathology that may have serious social, emotional, and professional consequences. […] Hyperhidrosis is the secretion of sweat in amounts greater than physiologically needed for thermoregulation. It is most commonly a chronic idiopathic (primary) condition; however, secondary medical conditions or medications should be excluded. Idiopathic hyperhidrosis localized to certain areas of the body is called primary focal hyperhidrosis. Primary focal hyperhidrosis usually affects the axillae, palms, and soles. The condition may also affect other sites, such as the face, scalp, inguinal, and inframammary areas. […] A consensus panel suggested the following diagnostic criteria for primary focal hyperhidrosis: Focal, visible, excessive sweating of at least six months duration without apparent cause.
- #2 Hyperhidrosis: Management Options | AAFPhttps://www.aafp.org/pubs/afp/issues/2018/0601/p729.html
Hyperhidrosis affects 1% to 3% of the U.S. population, yet less than one-half of those affected discuss this with their physician. More than 90% of hyperhidrosis cases are primary, and more than one-half of these cases affect the axillae. More than one-third of persons with axillary hyperhidrosis report that the condition is barely tolerable or completely intolerable, and it nearly always interferes with daily activities. Up to two-thirds of patients report a family history, suggesting a genetic predisposition. Although prevalence between sexes is roughly equal, women are more likely to report hyperhidrosis to their physician. […] Hyperhidrosis negatively impacts daily life, especially emotional well-being, self-esteem, interpersonal relationships, and occupational productivity. Although several tools have been developed to measure the impact of hyperhidrosis on quality of life, most are too complex to incorporate into office practice. The Hyperhidrosis Disease Severity Scale (HDSS) is a validated single-question survey with four grades of tolerability of sweating and impact on quality of life. This survey can estimate the effect on daily activities and response to treatment.
- #2 Epidemiology of Primary Hyperhidrosis – Focus on Hyperhidrosishttps://www.medpagetoday.com/resource-centers/focus-hyperhidrosis/epidemiology-primary-hyperhidrosis/2281
Data showed that multifocal hyperhidrosis is common with 81% of patients reporting three or more hyperhidrotic sites. […] Data presented as an abstract on „pediatric breaking news” showed that 17.1% of teens surveyed experience excessive, uncontrollable sweating based on published diagnostic criteria. […] Hyperhidrosis (extreme, uncontrollable sweating affecting 4.8% of people) is often misunderstood, misrepresented and mismanaged, but for the past 15 years the International Hyperhidrosis Society has been bringing the full range of stakeholders to the table to transform missed opportunities into an impactful mission. […] 85% waiting 3+ years to discuss excessive sweating with an HCP and 50% waiting 10+ years to do so. […] 27% never receiving diagnosis. […] Recent data (2018) found that 18% of Hh sufferers report an immediate family member also suffering from excessive sweating.
- #2https://www.termedia.pl/Hyperhidrosis-disease-aetiology-classification-and-r-nmanagement-in-the-light-of-modern-treatment-modalities,7,46948,1,1.html
The aetiology of excessive perspiration can be either primary or secondary to the systemic diseases. […] Hyperhidrosis has also a direct effect on skin condition by interfering with its natural protective mechanisms. This results in a greater prevalence of dermatoses among affected patients, especially of fungal, bacterial and less often viral origin. […] Nevertheless, the epidemiological studies conducted among large population in the United States of America and Canada estimated the global prevalence of primary hyperhidrosis equally at about 2.0-3.0% for men and women. […] Stefaniak et al. performed a research among Polish medical and dentistry students and discovered that the occurrence of hyperhidrosis reached up to 8.0% of the study group. […] A typical onset of symptoms is usually observed in individuals aged 14-25 years and their intensity mostly reduces with time.
- #2 Hyperhidrosis Market: Epidemiology, Industry Trends, Share, Size, Growth, Opportunity, and Forecast 2024-2034https://www.researchandmarkets.com/reports/5969816/hyperhidrosis-market-epidemiology-industry?srsltid=AfmBOoqchShHR2qXfHwIyUxSQk2C_ZTVoFwsqTYfPb0IQfOUOoKsOJwp
This report provides an exhaustive analysis of the hyperhidrosis market in the United States, EU5 (Germany, Spain, Italy, France, and United Kingdom) and Japan. […] According to the report the United States has the largest patient pool for hyperhidrosis and also represents the largest market for its treatment. […] This report is a must-read for manufacturers, investors, business strategists, researchers, consultants, and all those who have any kind of stake or are planning to foray into the hyperhidrosis market in any manner. […] What is the number of prevalent cases (2018-2034) of hyperhidrosis across the seven major markets? […] What are the key factors driving the epidemiological trend of hyperhidrosis? […] What will be the growth rate of patients across the seven major markets?
- #2 Hyperhidrosis Limits Patientsâ Daily Functioning, Quality of Life Across Several Different Regionshttps://www.hcplive.com/view/hyperhidrosis-limits-patients-daily-functioning-quality-of-life-across-several-different-regions
In this recent analysis of hyperhidrosis burden on patients, prevalence of the condition and its impacts on patients demonstrate the value of exploring knowledge gaps for this disease. […] The disease known as hyperhidrosis, a chronic skin condition known to cause excessive sweating, can result in significant psychological, physical, and economic burden for patients’ daily lives across several different regions, according to new findings, and its prevalence varies substantially across different populations. […] Little is known about the epidemiology and burden of hyperhidrosis across regions to date, Ikoma and colleagues wrote. Therefore, the objective of the project was to gather current evidence on the burden of hyperhidrosis by conducting targeted literature reviews (TLR) on epidemiology, and the human and economic burden posed on patients with this condition.
- #2 Hyperhidrosis Disease Burden Requires Further Understandinghttps://www.dermatologytimes.com/view/hyperhidrosis-disease-burden-requires-further-understanding
The cost of hospitalizations was found to be the highest in terms of economic burden of direct costs. […] Future actions should include implementation of educational programs for physicians, medical specialists, and patients to raise awareness of the condition; the conduct of further studies with larger scope and bigger patient populations; and the generation of more evidence for Japan, concluded the authors.
- #2 Epidemiology of Hyperhidrosis in Danish Blood Donors | HTML | Acta Dermato-Venereologicahttps://www.medicaljournals.se/acta/content/html/10.2340/00015555-3790
This retrospective cohort study found that the prevalence of self-reported HH in blood donors was in line with previous reports. The prevalence of hospital-diagnosed HH was lower than previously reported. This may be the result of selection bias, as blood donors are implicitly healthy and have fewer diagnoses than the general population, or that individuals with hospital-diagnosed HH were receiving medications that precluded blood donation and thus study participation. […] We speculate that several factors contribute to the differences in prevalence, lifestyle habits, SES and income between self-reported and hospital-diagnosed HH. Firstly, low awareness of HH in the public, the stigma surrounding excessive sweating and seeking help for sweating, and the notion that treatments are futile lead to most adults with HH not seeking medical help for sweating. Next, lack of awareness of diagnostics and treatments for HH in physicians, and the seemingly benign symptomatology of HH, lead to many who seek help for HH not being given adequate treatment or referred to dermatologists.
- #3 Epidemiology of Primary Hyperhidrosis – Focus on Hyperhidrosishttps://www.medpagetoday.com/resource-centers/focus-hyperhidrosis/epidemiology-primary-hyperhidrosis/2281
In the past, there was little data on the prevalence of primary hyperhidrosis (Hh). Recently, however, more studies have been published in the medical literature – with illuminating statistics: […] Researchers reported the prevalence of hyperhidrosis in the United States as 4.8%, representing approximately 15.3 million people. Thatâs almost twice as many people as previously believed and this makes Hh more common than autism, melanoma, psoriasis, and peanut allergies. […] A study showed that, in Sweden, prevalence of primary hyperhidrosis was 5.5% with severe, primary hyperhidrosis affecting 1.4% of the population. Secondary hyperhidrosis was observed in 14.8% of the study participants. […] Research results found that the prevalence of primary hyperhidrosis among dermatology outpatients in Shanghai was 14.5% and in Vancouver was 12.3%.
- #3 Azthena logo with the word Azthenahttps://www.news-medical.net/health/Hyperhidrosis-Prognosis-and-Epidemiology.aspx
Hyperhidrosis refers to excessive sweating that does not necessarily occur in response to the body becoming overheated by exercise or a hot environment, for example. […] It is difficult to say how many people develop hyperhidrosis as there are no guidelines to determine exactly what constitutes normal sweating, but estimates suggest that the worldwide prevalence is between 2% and 4%, without any particular gender predisposition. […] There are differences in prevalence globally, with one study, for example, having shown a prevalence of 2.9% in the US and up to 5.0% prevalence in certain areas of China.
- #3 Hyperhidrosis: Management Options | AAFPhttps://www.aafp.org/pubs/afp/issues/2018/0601/p729.html
Hyperhidrosis affects 1% to 3% of the U.S. population, yet less than one-half of those affected discuss this with their physician. More than 90% of hyperhidrosis cases are primary, and more than one-half of these cases affect the axillae. More than one-third of persons with axillary hyperhidrosis report that the condition is barely tolerable or completely intolerable, and it nearly always interferes with daily activities. Up to two-thirds of patients report a family history, suggesting a genetic predisposition. Although prevalence between sexes is roughly equal, women are more likely to report hyperhidrosis to their physician. […] Hyperhidrosis negatively impacts daily life, especially emotional well-being, self-esteem, interpersonal relationships, and occupational productivity. Although several tools have been developed to measure the impact of hyperhidrosis on quality of life, most are too complex to incorporate into office practice. The Hyperhidrosis Disease Severity Scale (HDSS) is a validated single-question survey with four grades of tolerability of sweating and impact on quality of life. This survey can estimate the effect on daily activities and response to treatment.
- #3 Hyperhidrosis: Background, Pathophysiology, Etiologyhttps://emedicine.medscape.com/article/1073359-overview
In the United States and the United Kingdom, 1-1.6% of people have records reflecting hyperhidrosis. About 60% in both databases were women. […] In adolescents and young adults, an incidence rate of 0.6-1% is reported for hyperhidrosis. […] Palmoplantar hyperhidrosis occurs 20 times more frequently in the Japanese than in any other ethnic group. […] All races can be affected by hyperhidrosis; however, Japanese are reportedly affected more than 20 times more frequently than other ethnic groups. […] Both sexes can be affected by hyperhidrosis. […] Persons of all ages can be affected by hyperhidrosis. Localized hyperhidrosis, unlike generalized hyperhidrosis, usually begins in childhood or adolescence. In a study of 850 patients with palmar, axillary, or facial hyperhidrosis, 62% of patients reported that sweating began since before they could remember; 33%, since puberty; and 5%, during adulthood.
- #3 Epidemiology of Primary Hyperhidrosis – Focus on Hyperhidrosishttps://www.medpagetoday.com/resource-centers/focus-hyperhidrosis/epidemiology-primary-hyperhidrosis/2281
Data showed that multifocal hyperhidrosis is common with 81% of patients reporting three or more hyperhidrotic sites. […] Data presented as an abstract on „pediatric breaking news” showed that 17.1% of teens surveyed experience excessive, uncontrollable sweating based on published diagnostic criteria. […] Hyperhidrosis (extreme, uncontrollable sweating affecting 4.8% of people) is often misunderstood, misrepresented and mismanaged, but for the past 15 years the International Hyperhidrosis Society has been bringing the full range of stakeholders to the table to transform missed opportunities into an impactful mission. […] 85% waiting 3+ years to discuss excessive sweating with an HCP and 50% waiting 10+ years to do so. […] 27% never receiving diagnosis. […] Recent data (2018) found that 18% of Hh sufferers report an immediate family member also suffering from excessive sweating.
- #3 Hyperhidrosis – Symptoms and causes – Mayo Clinichttps://www.mayoclinic.org/diseases-conditions/hyperhidrosis/symptoms-causes/syc-20367152
Hyperhidrosis (hi-pur-hi-DROE-sis) is excessive sweating that’s not always related to heat or exercise. Heavy sweating can disrupt your day and cause social anxiety and embarrassment. […] Hyperhidrosis treatment usually helps. […] Primary hyperhidrosis is caused by faulty nerve signals that trigger eccrine sweat glands to become overactive. It usually affects the palms, soles, underarms and sometimes the face. […] There is no medical cause for this type of hyperhidrosis. It can run in families. […] Secondary hyperhidrosis is caused by an underlying medical condition or by taking certain medications, such as pain relievers, antidepressants, and some diabetes and hormonal medications. […] Risk factors for hyperhidrosis include: Having a blood relative, such as a parent, sibling or grandparent, who sweats heavily. […] Complications of hyperhidrosis include: People who sweat a lot are more prone to skin infections. […] Your condition may affect your pursuit of work and educational goals.
- #3 Hyperhidrosis – StatPearls – NCBI Bookshelfhttps://www.ncbi.nlm.nih.gov/books/NBK459227/
Hyperhidrosis affects approximately 3% of the United States population and is most common in patients between 20 to 60 years of age. No evidence shows that either men or women are at increased risk. The palmar region is the most commonly affected area. Hyperhidrosis affects all races, but data show that the Japanese are more affected than any other ethnic group. […] Studies have shown that the prevalence of this disorder is approximately 3% in the United States. Hyperhidrosis can result in emotional, psychological, social, and occupational impairment.
- #3 Primary hyperhidrosis prevalence and characteristics among medical students in Rio de Janeiro | PLOS Onehttps://journals.plos.org/plosone/article?id=10.1371/journal.pone.0220664
Hyperhidrosis is a pathological condition defined by excessive sweating beyond thermoregulatory physiological needs, which can cause substantial psychological impact and impairment of daily activities. […] PH prevalence among Rio de Janeiro medical students was 20.56%, similar between men and women, predominating associated presentations, axillary, palmar and plantar sites, strong familial history, age of onset before 18 years, and some degree of life impairment. […] PH prevalence, however, is poorly verified. […] Our 20.56% PH prevalence finding was higher than those of the studies also among medical students in Aracaju, Brazil (14.76%) […] We found strong association between family history of PH and occurrence of the disease, with a prevalence ratio of 4.27. […] Our study has shown 86.84% of PH participants reported some degree of impact on quality of life.
- #3 Epidemiology of Hyperhidrosis in Danish Blood Donors | HTML | Acta Dermato-Venereologicahttps://www.medicaljournals.se/acta/content/html/10.2340/00015555-3790
Epidemiology of Hyperhidrosis in Danish Blood Donors […] The objectives of this retrospective cohort study were to estimate the prevalence of hyperhidrosis and to compare demographic, lifestyle, and socioeconomic parameters in blood donors with and without self-reported or hospital-diagnosed hyperhidrosis. Overall, 2,794 of 30,808 blood donors (9.07%; 95% confidence interval (95% CI) 8.759.40) had self-reported hyperhidrosis and 284 of 122,225 (0.23%; 95% CI 0.210.26) had hospital-diagnosed hyperhidrosis. Self-reported hyperhidrosis was associated with smoking (odds ratio (OR) 1.17; 95% CI 1.051.31), overweight (OR 1.72; 95% CI 1.581.87), unemployed (OR 1.60; 95% CI 1.242.08), short education (OR 0.76; 95% CI 0.640.90), and lower income (beta-coefficient 26,121; 95% CI 37,931, 14,311). Hospital-diagnosed hyperhidrosis did not differ from controls. Thus, self-reported hyperhidrosis was associated with potential hyperhidrosis risk factors (smoking, overweight) and disease implications (unemployment, low education level and income).
- #3 Hyperhidrosis Disease Burden Requires Further Understandinghttps://www.dermatologytimes.com/view/hyperhidrosis-disease-burden-requires-further-understanding
The cost of hospitalizations was found to be the highest in terms of economic burden of direct costs. […] Future actions should include implementation of educational programs for physicians, medical specialists, and patients to raise awareness of the condition; the conduct of further studies with larger scope and bigger patient populations; and the generation of more evidence for Japan, concluded the authors.
- #3 SciELO Brasil – Hyperhidrosis: prevalence and impact on quality of life Hyperhidrosis: prevalence and impact on quality of lifehttps://www.scielo.br/j/jbpneu/a/gxS3VxQSW3j7hX5MkLXDxqz/
Objective: To determine the prevalence of primary hyperhidrosis in the city of Botucatu, Brazil, and to evaluate how this disorder affects the quality of life in those suffering from it. […] A total of 4,133 residents, in 1,351 households, were surveyed. Excessive sweating was reported by 85 residents (prevalence = 2.07%), of whom 51 (60%) were female. […] Although the prevalence of self-reported excessive sweating was greater than 2%, the actual prevalence of primary hyperhidrosis in our sample was 0.93% and nearly 50% of the respondents with primary hyperhidrosis reported impaired quality of life. […] There are few data on the worldwide prevalence of hyperhidrosis, reported values ranging from 0.072% to 9%. […] In our study, the prevalence of hyperhidrosis after the application of a questionnaire by trained interviewers was above 2%, as observed by Strutton et al. However, after medical evaluation, 25% of the patients that reported excessive sweating actually showed normal sweating and 30% had SH. Consequently, more than half of the subjects that reported excessive sweating did not actually have PH. Therefore, after medical evaluation, the estimated prevalence of PH decreased to less than 1%.
- #4http://umu.diva-portal.org/smash/record.jsf?pid=diva2:1192575
Primary hyperhidrosis, excessive sweating, is a condition with unknown prevalence in many parts of the world. […] Our results showed that primary hyperhidrosis occurs in 5.5% of the Swedish population. The disease reduces quality of life and affects mainly the psychological health of the individuals. […] The prevalence of primary hyperhidrosis was 5.5%, and severe primary hyperhidrosis (HDSS 3-4 points) occurred in 1.4%. […] Hyperhidrosis affects individuals in adolescence as a focal form while occurring as a generalised form with increasing age. Further, the prevalence of primary hyperhidrosis described in our study is comparable to other studies from the western hemisphere. […] Primary hyperhidrosis mainly impairs mental rather than physical aspects of life and also interferes with specific daily activities of the affected individuals. […] Primary hyperhidrosis reduces quality of life and interferes with daily activities of those affected.
- #4https://www.termedia.pl/Hyperhidrosis-disease-aetiology-classification-and-r-nmanagement-in-the-light-of-modern-treatment-modalities,7,46948,1,1.html
The aetiology of excessive perspiration can be either primary or secondary to the systemic diseases. […] Hyperhidrosis has also a direct effect on skin condition by interfering with its natural protective mechanisms. This results in a greater prevalence of dermatoses among affected patients, especially of fungal, bacterial and less often viral origin. […] Nevertheless, the epidemiological studies conducted among large population in the United States of America and Canada estimated the global prevalence of primary hyperhidrosis equally at about 2.0-3.0% for men and women. […] Stefaniak et al. performed a research among Polish medical and dentistry students and discovered that the occurrence of hyperhidrosis reached up to 8.0% of the study group. […] A typical onset of symptoms is usually observed in individuals aged 14-25 years and their intensity mostly reduces with time.
- #4 Hyperhidrosishttps://mobile.fpnotebook.com/Derm/Sweat/Hyprhdrs.htm
Prevalence: 1-3% of U.S. […] Both genders affected equally (women report more often)
- #4 Hyperhidrosis Market Size, Share | Industry Forecast, 2034https://www.imarcgroup.com/hyperhidrosis-market
The 7 major hyperhidrosis markets reached a value of US$ 426.7 Million in 2023. Looking forward, IMARC Group expects the 7MM to reach US$ 651.2 Million by 2034, exhibiting a growth rate (CAGR) of 3.92% during 2024-2034. […] Hyperhidrosis affects at least 176 million people globally. […] The prevalence of hyperhidrosis is approximately 15.3 million people in the US population. […] The prevalence rate is 2.1% among children and adolescents and people 65 years of age and beyond, with the largest rates occurring in the 18-39 age group (8.8%). […] In India, hyperhidrosis affects about 2.5-3 percent of the population.
- #4 Epidemiology of Primary Hyperhidrosis – International Hyperhidrosis Society | Official Sitehttps://www.sweathelp.org/about-hyperhidrosis/epidemiology-of-primary-hyperhidrosis.html
Results showed that the prevalence of hyperhidrosis in the U.S. was 2.8% (7.8 million Americans). […] Recent data (2018) found that 18% of Hh sufferers report an immediate family member also suffering from excessive sweating. […] A series of studies on patients treated by endoscopic thoracic sympathectomy (ETS) reported a family history in 35% and 56% of participants. […] A study of the familial aggregation of hyperhidrosis also suggested that the disorder may be more common than previously thought. […] Focal primary hyperhidrosis has an onset during childhood or adolescence. […] This 2016 study also showed that hyperhidrosis is often a lifelong struggle with symptom severity FAILING to lessen with age — 88% reported that symptoms have become worse or stayed the same over time. […] In 2016, results from 1,985 survey participants showed that axillary hyperhidrosis was the most prevalent type of hyperhidrosis in the study sample (68%) followed by palmar (65%) and plantar (64%). […] It should be noted here, again, the primary focal Hh is most typically a multifocal disease. […] Key take-aways: primary Hh is relatively common, multifocal, and chronic with an onset in youth and an apparent genetic link — yet, diagnosis and treatment is often delayed for years.
- #4 Epidemiology of Primary Hyperhidrosis – Focus on Hyperhidrosishttps://www.medpagetoday.com/resource-centers/focus-hyperhidrosis/epidemiology-primary-hyperhidrosis/2281
In the past, there was little data on the prevalence of primary hyperhidrosis (Hh). Recently, however, more studies have been published in the medical literature – with illuminating statistics: […] Researchers reported the prevalence of hyperhidrosis in the United States as 4.8%, representing approximately 15.3 million people. Thatâs almost twice as many people as previously believed and this makes Hh more common than autism, melanoma, psoriasis, and peanut allergies. […] A study showed that, in Sweden, prevalence of primary hyperhidrosis was 5.5% with severe, primary hyperhidrosis affecting 1.4% of the population. Secondary hyperhidrosis was observed in 14.8% of the study participants. […] Research results found that the prevalence of primary hyperhidrosis among dermatology outpatients in Shanghai was 14.5% and in Vancouver was 12.3%.
- #4 Epidemiology of Primary Hyperhidrosis – International Hyperhidrosis Society | Official Sitehttps://www.sweathelp.org/about-hyperhidrosis/epidemiology-of-primary-hyperhidrosis.html
In the past, there was little data on the prevalence of primary hyperhidrosis (Hh). Recently, however, more studies have been published in the medical literature – with illuminating statistics: […] Researchers reported the prevalence of hyperhidrosis in the United States as 4.8%, representing approximately 15.3 million people. […] A study showed that, in Sweden, prevalence of primary hyperhidrosis was 5.5% with severe, primary hyperhidrosis affecting 1.4% of the population. […] Research results found that the prevalence of primary hyperhidrosis among dermatology outpatients in Shanghai was 14.5% and in Vancouver was 12.3%. […] Data showed that multifocal hyperhidrosis is common with 81% of patients reporting three or more hyperhidrotic sites. […] Data presented as an abstract on „pediatric breaking news” showed that 17.1% of teens surveyed experience excessive, uncontrollable sweating based on published diagnostic criteria.
- #4 Hyperhidrosis: Management Options | AAFPhttps://www.aafp.org/pubs/afp/issues/2018/0601/p729.html
Hyperhidrosis affects 1% to 3% of the U.S. population, yet less than one-half of those affected discuss this with their physician. More than 90% of hyperhidrosis cases are primary, and more than one-half of these cases affect the axillae. More than one-third of persons with axillary hyperhidrosis report that the condition is barely tolerable or completely intolerable, and it nearly always interferes with daily activities. Up to two-thirds of patients report a family history, suggesting a genetic predisposition. Although prevalence between sexes is roughly equal, women are more likely to report hyperhidrosis to their physician. […] Hyperhidrosis negatively impacts daily life, especially emotional well-being, self-esteem, interpersonal relationships, and occupational productivity. Although several tools have been developed to measure the impact of hyperhidrosis on quality of life, most are too complex to incorporate into office practice. The Hyperhidrosis Disease Severity Scale (HDSS) is a validated single-question survey with four grades of tolerability of sweating and impact on quality of life. This survey can estimate the effect on daily activities and response to treatment.
- #4 Epidemiology of Primary Hyperhidrosis – Focus on Hyperhidrosishttps://www.medpagetoday.com/resource-centers/focus-hyperhidrosis/epidemiology-primary-hyperhidrosis/2281
A series of studies on patients treated by endoscopic thoracic sympathectomy (ETS) reported a family history in 35% and 56% of participants. […] A study of the familial aggregation of hyperhidrosis also suggested that the disorder may be more common than previously thought. […] Focal primary hyperhidrosis usually has an onset during childhood or adolescence. […] This 2016 study also showed that hyperhidrosis is often a lifelong struggle with symptom severity FAILING to lessen with age — 88% reported that symptoms have become worse or stayed the same over time. […] Key take-aways: primary Hh is relatively common, multifocal, and chronic with an onset in youth and an apparent genetic link — yet, diagnosis and treatment is often delayed for years.
- #4 Epidemiology of Hyperhidrosis in Danish Blood Donors | HTML | Acta Dermato-Venereologicahttps://www.medicaljournals.se/acta/content/html/10.2340/00015555-3790
The prevalence of hospital-diagnosed HH is clearly lower than the prevalence of self-reported HH. Self-reported HH is associated with potential HH risk factors (i.e. smoking and overweight) and potential disease implications (i.e. unemployment, low education level and income). In contrast, hospital-diagnosed HH does not differ from controls on these parameters.
- #4 Hyperhidrosis Disease Burden Requires Further Understandinghttps://www.dermatologytimes.com/view/hyperhidrosis-disease-burden-requires-further-understanding
More understanding of the physical, psychological, and economic burdens of hyperhidrosis is needed. […] Hyperhidrosis is a chronic skin condition characterized by excessive sweating, and patients can incur costs that are associated with attempting to manage and hide excessive sweating, which can be embarrassing. […] The incidence of hyperhidrosis fluctuated from 0.13% in the UK to 0.28% in the United States, with a higher rate in female patients. The prevalence ranged from 2.8% to 4.8% in the US general population to 18.4% in Chinese inpatients, whereas the prevalence of axillary hyperhidrosis ranged from 1.4% in the US general population to 5.75% in Japanese employees/students. […] There was little evidence of the hyperhidrosis burden, especially among Japanese patients, but the burden was high and decreased patients daily functioning.
- #4 SciELO Brasil – Hyperhidrosis: prevalence and impact on quality of life Hyperhidrosis: prevalence and impact on quality of lifehttps://www.scielo.br/j/jbpneu/a/gxS3VxQSW3j7hX5MkLXDxqz/
Objective: To determine the prevalence of primary hyperhidrosis in the city of Botucatu, Brazil, and to evaluate how this disorder affects the quality of life in those suffering from it. […] A total of 4,133 residents, in 1,351 households, were surveyed. Excessive sweating was reported by 85 residents (prevalence = 2.07%), of whom 51 (60%) were female. […] Although the prevalence of self-reported excessive sweating was greater than 2%, the actual prevalence of primary hyperhidrosis in our sample was 0.93% and nearly 50% of the respondents with primary hyperhidrosis reported impaired quality of life. […] There are few data on the worldwide prevalence of hyperhidrosis, reported values ranging from 0.072% to 9%. […] In our study, the prevalence of hyperhidrosis after the application of a questionnaire by trained interviewers was above 2%, as observed by Strutton et al. However, after medical evaluation, 25% of the patients that reported excessive sweating actually showed normal sweating and 30% had SH. Consequently, more than half of the subjects that reported excessive sweating did not actually have PH. Therefore, after medical evaluation, the estimated prevalence of PH decreased to less than 1%.
- #4 Epidemiology of hyperhidrosis in 2 population-based health care databases – EM consultehttps://www.em-consulte.com/es/article/1193840/resume/epidemiology-of-hyperhidrosis-in-2-population-base
Epidemiology of hyperhidrosis in 2 population-based health care databases – 13/01/18 […] Population-based and clinical case reports of hyperhidrosis (HH) provide prevalence estimates that vary widely across reported studies because of differences in case ascertainment. […] In this study, we specify diagnostic, symptom, and prescription codes for HH to estimate incidence and prevalence for the United Kingdom and the United States. […] Data from UK and US health care databases were analyzed to ascertain HH cases and estimate incidence and prevalence from health care records during calendar years 2011 through 2013. […] On the basis of 2013 data for the United States and United Kingdom, between 1.0% and 1.6% of these populations have health care records indicating diagnosis or treatment of HH. Women accounted for approximately 60% of incident and prevalent cases in both databases. […] The findings represent a plausible estimate for incidence and prevalence of HH among persons seeking medical care for excessive sweating. Improved practices for identifying HH in clinical settings may increase the sensitivity and specificity of future studies and improve characterization and quantification of the population burden of this significant disease.
- #4 Hyperhidrosis and Its Impact on Those Living With Ithttps://www.ajmc.com/view/hyperhidrosis-and-its-impact–on-those-living-with-it
Hyperhidrosis affects approximately 4.8% of Americans. […] Primary hyperhidrosis reportedly affects 4.8% of Americans, or approximately 15.3 million individuals. […] Because it is often underreported and underdiagnosed, the true prevalence rates may be higher. […] The age of onset of primary hyperhidrosis is often between 14 and 25 years. […] It primarily affects younger adults aged 18 to 39 years. […] Rates are lowest among those 65 years and older, young children, and adolescents. […] It is speculated that lower prevalence among the elderly population is due to disease regression over time. […] Incidence rates do not appear to differ between genders. […] However, men may be more likely to be affected in craniofacial areas, although women are more likely to be affected in axillae areas.
- #5 Epidemiology of Primary Hyperhidrosis – International Hyperhidrosis Society | Official Sitehttps://www.sweathelp.org/about-hyperhidrosis/epidemiology-of-primary-hyperhidrosis.html
In the past, there was little data on the prevalence of primary hyperhidrosis (Hh). Recently, however, more studies have been published in the medical literature – with illuminating statistics: […] Researchers reported the prevalence of hyperhidrosis in the United States as 4.8%, representing approximately 15.3 million people. […] A study showed that, in Sweden, prevalence of primary hyperhidrosis was 5.5% with severe, primary hyperhidrosis affecting 1.4% of the population. […] Research results found that the prevalence of primary hyperhidrosis among dermatology outpatients in Shanghai was 14.5% and in Vancouver was 12.3%. […] Data showed that multifocal hyperhidrosis is common with 81% of patients reporting three or more hyperhidrotic sites. […] Data presented as an abstract on „pediatric breaking news” showed that 17.1% of teens surveyed experience excessive, uncontrollable sweating based on published diagnostic criteria.
- #5 Hyperhidrosis and Its Impact on Those Living With Ithttps://www.ajmc.com/view/hyperhidrosis-and-its-impact–on-those-living-with-it
Hyperhidrosis affects approximately 4.8% of Americans. […] Primary hyperhidrosis reportedly affects 4.8% of Americans, or approximately 15.3 million individuals. […] Because it is often underreported and underdiagnosed, the true prevalence rates may be higher. […] The age of onset of primary hyperhidrosis is often between 14 and 25 years. […] It primarily affects younger adults aged 18 to 39 years. […] Rates are lowest among those 65 years and older, young children, and adolescents. […] It is speculated that lower prevalence among the elderly population is due to disease regression over time. […] Incidence rates do not appear to differ between genders. […] However, men may be more likely to be affected in craniofacial areas, although women are more likely to be affected in axillae areas.
- #5 Epidemiology of Primary Hyperhidrosis – Focus on Hyperhidrosishttps://www.medpagetoday.com/resource-centers/focus-hyperhidrosis/epidemiology-primary-hyperhidrosis/2281
A series of studies on patients treated by endoscopic thoracic sympathectomy (ETS) reported a family history in 35% and 56% of participants. […] A study of the familial aggregation of hyperhidrosis also suggested that the disorder may be more common than previously thought. […] Focal primary hyperhidrosis usually has an onset during childhood or adolescence. […] This 2016 study also showed that hyperhidrosis is often a lifelong struggle with symptom severity FAILING to lessen with age — 88% reported that symptoms have become worse or stayed the same over time. […] Key take-aways: primary Hh is relatively common, multifocal, and chronic with an onset in youth and an apparent genetic link — yet, diagnosis and treatment is often delayed for years.
- #5 Epidemiology of Primary Hyperhidrosis – Focus on Hyperhidrosishttps://www.medpagetoday.com/resource-centers/focus-hyperhidrosis/epidemiology-primary-hyperhidrosis/2281
Data showed that multifocal hyperhidrosis is common with 81% of patients reporting three or more hyperhidrotic sites. […] Data presented as an abstract on „pediatric breaking news” showed that 17.1% of teens surveyed experience excessive, uncontrollable sweating based on published diagnostic criteria. […] Hyperhidrosis (extreme, uncontrollable sweating affecting 4.8% of people) is often misunderstood, misrepresented and mismanaged, but for the past 15 years the International Hyperhidrosis Society has been bringing the full range of stakeholders to the table to transform missed opportunities into an impactful mission. […] 85% waiting 3+ years to discuss excessive sweating with an HCP and 50% waiting 10+ years to do so. […] 27% never receiving diagnosis. […] Recent data (2018) found that 18% of Hh sufferers report an immediate family member also suffering from excessive sweating.
- #5 Hyperhidrosis – StatPearls – NCBI Bookshelfhttps://www.ncbi.nlm.nih.gov/books/NBK459227/
Hyperhidrosis affects approximately 3% of the United States population and is most common in patients between 20 to 60 years of age. No evidence shows that either men or women are at increased risk. The palmar region is the most commonly affected area. Hyperhidrosis affects all races, but data show that the Japanese are more affected than any other ethnic group. […] Studies have shown that the prevalence of this disorder is approximately 3% in the United States. Hyperhidrosis can result in emotional, psychological, social, and occupational impairment.
- #5 Epidemiology of Primary Hyperhidrosis – International Hyperhidrosis Society | Official Sitehttps://www.sweathelp.org/about-hyperhidrosis/epidemiology-of-primary-hyperhidrosis.html
Results showed that the prevalence of hyperhidrosis in the U.S. was 2.8% (7.8 million Americans). […] Recent data (2018) found that 18% of Hh sufferers report an immediate family member also suffering from excessive sweating. […] A series of studies on patients treated by endoscopic thoracic sympathectomy (ETS) reported a family history in 35% and 56% of participants. […] A study of the familial aggregation of hyperhidrosis also suggested that the disorder may be more common than previously thought. […] Focal primary hyperhidrosis has an onset during childhood or adolescence. […] This 2016 study also showed that hyperhidrosis is often a lifelong struggle with symptom severity FAILING to lessen with age — 88% reported that symptoms have become worse or stayed the same over time. […] In 2016, results from 1,985 survey participants showed that axillary hyperhidrosis was the most prevalent type of hyperhidrosis in the study sample (68%) followed by palmar (65%) and plantar (64%). […] It should be noted here, again, the primary focal Hh is most typically a multifocal disease. […] Key take-aways: primary Hh is relatively common, multifocal, and chronic with an onset in youth and an apparent genetic link — yet, diagnosis and treatment is often delayed for years.
- #5 Focus on Hyperhidrosishttps://www.medpagetoday.com/resource-centers/focus-hyperhidrosis
Our understanding of the international prevalence, clinical characteristics, and patient burden of primary hyperhidrosis is expanding rapidly. Hereâs a snapshot. […] Hyperhidrosis is a common side effect of antidepressants and can lead to treatment discontinuation. A recent meta-analysis suggests that the risk of hyperhidrosis differs by medication and is associated with the dopamine transporter. […] A recent study suggests that people with atopic dermatitis experience changes in sweat gland nervous activation and a higher frequency of hyperhidrosis, or excessive sweating. Other studies have shown different effects, though.
- #5 Hyperhidrosis prevalence and its impact on population – Hasimoto – Shanghai Chesthttps://shc.amegroups.org/article/view/5114/html
Hyperhidrosis is a disorder characterized by excessive sweating which beyond the physiological need for body thermoregulation. The prevalence data available in the literature are practically nonexistent up to the beginning of the 21st century. The prevalence found in the articles varied from 0.072% to 16.3%. As to the impact on the quality of life, all articles have shown that such disorder affects in some way the life of the individuals. The data available in the literature regarding the prevalence of hyperhidrosis in the world population are practically nonexistent until the beginning of the 21st century, therefore up to some time ago little was known about the number of individuals bearing this disorder. The bibliographic review was done by using the PubMed database (until January 10th 2019). Sixteen articles that evaluated the prevalence of hyperhidrosis were found in the research, 15 of them were published from the 21st century. The prevalence of hyperhidrosis found in the articles ranged from 0.072% to 16.3%. The first citation found in the literature about the prevalence of hyperhidrosis is from 1977. The first published work with methodological description was the one by Strutton et al. in 2004. In 2007 China published two studies about the prevalence of hyperhidrosis. The lowest prevalence of published hyperhidrosis was 0.072%, by Chu et al. The highest prevalence published among all published papers was the one by Augustin et al. in 2013. The most recent work about the prevalence of hyperhidrosis belongs to our group, published in 2018. The existing data of hyperhidrosis prevalence in the world population are well varied and questionable due to the heterogeneity of methodologies used in several studies. The impacts of hyperhidrosis in the quality of life of the individuals are well known in daily practice and are confirmed by means of the applied questionnaires aimed at measuring the severity and the interference of the disorder in the daily life of its patient.
- #5 Primary Hyperhidrosis: Understanding Its Impact and Exploring Treatment Optionshttps://www.rupahealth.com/post/primary-hyperhidrosis-understanding-its-impact-and-exploring-treatment-options
Studies have shown that about 30% to 50% of individuals with primary hyperhidrosis have a family history of the condition, suggesting a hereditary predisposition. […] Primary hyperhidrosis is a chronic condition characterized by excessive and uncontrollable sweating, affecting specific areas of the body such as the hands, feet, underarms, and face. […] A variety of management options are available, including topical antiperspirants, oral medications, iontophoresis, Botox injections, and surgical options for severe cases. […] Early intervention and support can make a substantial difference in managing the challenges of living with primary hyperhidrosis.
- #6 Epidemiology of Primary Hyperhidrosis – Focus on Hyperhidrosishttps://www.medpagetoday.com/resource-centers/focus-hyperhidrosis/epidemiology-primary-hyperhidrosis/2281
In the past, there was little data on the prevalence of primary hyperhidrosis (Hh). Recently, however, more studies have been published in the medical literature – with illuminating statistics: […] Researchers reported the prevalence of hyperhidrosis in the United States as 4.8%, representing approximately 15.3 million people. Thatâs almost twice as many people as previously believed and this makes Hh more common than autism, melanoma, psoriasis, and peanut allergies. […] A study showed that, in Sweden, prevalence of primary hyperhidrosis was 5.5% with severe, primary hyperhidrosis affecting 1.4% of the population. Secondary hyperhidrosis was observed in 14.8% of the study participants. […] Research results found that the prevalence of primary hyperhidrosis among dermatology outpatients in Shanghai was 14.5% and in Vancouver was 12.3%.
- #6 Epidemiology of Primary Hyperhidrosis – International Hyperhidrosis Society | Official Sitehttps://www.sweathelp.org/about-hyperhidrosis/epidemiology-of-primary-hyperhidrosis.html
In the past, there was little data on the prevalence of primary hyperhidrosis (Hh). Recently, however, more studies have been published in the medical literature – with illuminating statistics: […] Researchers reported the prevalence of hyperhidrosis in the United States as 4.8%, representing approximately 15.3 million people. […] A study showed that, in Sweden, prevalence of primary hyperhidrosis was 5.5% with severe, primary hyperhidrosis affecting 1.4% of the population. […] Research results found that the prevalence of primary hyperhidrosis among dermatology outpatients in Shanghai was 14.5% and in Vancouver was 12.3%. […] Data showed that multifocal hyperhidrosis is common with 81% of patients reporting three or more hyperhidrotic sites. […] Data presented as an abstract on „pediatric breaking news” showed that 17.1% of teens surveyed experience excessive, uncontrollable sweating based on published diagnostic criteria.
- #6 Epidemiology of Hyperhidrosis in Danish Blood Donors | HTML | Acta Dermato-Venereologicahttps://www.medicaljournals.se/acta/content/html/10.2340/00015555-3790
Epidemiology of Hyperhidrosis in Danish Blood Donors […] The objectives of this retrospective cohort study were to estimate the prevalence of hyperhidrosis and to compare demographic, lifestyle, and socioeconomic parameters in blood donors with and without self-reported or hospital-diagnosed hyperhidrosis. Overall, 2,794 of 30,808 blood donors (9.07%; 95% confidence interval (95% CI) 8.759.40) had self-reported hyperhidrosis and 284 of 122,225 (0.23%; 95% CI 0.210.26) had hospital-diagnosed hyperhidrosis. Self-reported hyperhidrosis was associated with smoking (odds ratio (OR) 1.17; 95% CI 1.051.31), overweight (OR 1.72; 95% CI 1.581.87), unemployed (OR 1.60; 95% CI 1.242.08), short education (OR 0.76; 95% CI 0.640.90), and lower income (beta-coefficient 26,121; 95% CI 37,931, 14,311). Hospital-diagnosed hyperhidrosis did not differ from controls. Thus, self-reported hyperhidrosis was associated with potential hyperhidrosis risk factors (smoking, overweight) and disease implications (unemployment, low education level and income).
- #6 Epidemiology of Primary Hyperhidrosis – International Hyperhidrosis Society | Official Sitehttps://www.sweathelp.org/about-hyperhidrosis/epidemiology-of-primary-hyperhidrosis.html
Results showed that the prevalence of hyperhidrosis in the U.S. was 2.8% (7.8 million Americans). […] Recent data (2018) found that 18% of Hh sufferers report an immediate family member also suffering from excessive sweating. […] A series of studies on patients treated by endoscopic thoracic sympathectomy (ETS) reported a family history in 35% and 56% of participants. […] A study of the familial aggregation of hyperhidrosis also suggested that the disorder may be more common than previously thought. […] Focal primary hyperhidrosis has an onset during childhood or adolescence. […] This 2016 study also showed that hyperhidrosis is often a lifelong struggle with symptom severity FAILING to lessen with age — 88% reported that symptoms have become worse or stayed the same over time. […] In 2016, results from 1,985 survey participants showed that axillary hyperhidrosis was the most prevalent type of hyperhidrosis in the study sample (68%) followed by palmar (65%) and plantar (64%). […] It should be noted here, again, the primary focal Hh is most typically a multifocal disease. […] Key take-aways: primary Hh is relatively common, multifocal, and chronic with an onset in youth and an apparent genetic link — yet, diagnosis and treatment is often delayed for years.
- #6 Epidemiology of Primary Hyperhidrosis – Focus on Hyperhidrosishttps://www.medpagetoday.com/resource-centers/focus-hyperhidrosis/epidemiology-primary-hyperhidrosis/2281
A series of studies on patients treated by endoscopic thoracic sympathectomy (ETS) reported a family history in 35% and 56% of participants. […] A study of the familial aggregation of hyperhidrosis also suggested that the disorder may be more common than previously thought. […] Focal primary hyperhidrosis usually has an onset during childhood or adolescence. […] This 2016 study also showed that hyperhidrosis is often a lifelong struggle with symptom severity FAILING to lessen with age — 88% reported that symptoms have become worse or stayed the same over time. […] Key take-aways: primary Hh is relatively common, multifocal, and chronic with an onset in youth and an apparent genetic link — yet, diagnosis and treatment is often delayed for years.
- #6 Focus on Hyperhidrosishttps://www.medpagetoday.com/resource-centers/focus-hyperhidrosis
Our understanding of the international prevalence, clinical characteristics, and patient burden of primary hyperhidrosis is expanding rapidly. Hereâs a snapshot. […] Hyperhidrosis is a common side effect of antidepressants and can lead to treatment discontinuation. A recent meta-analysis suggests that the risk of hyperhidrosis differs by medication and is associated with the dopamine transporter. […] A recent study suggests that people with atopic dermatitis experience changes in sweat gland nervous activation and a higher frequency of hyperhidrosis, or excessive sweating. Other studies have shown different effects, though.
- #7 Hyperhidrosis Limits Patientsâ Daily Functioning, Quality of Life Across Several Different Regionshttps://www.consultantlive.com/view/hyperhidrosis-limits-patients-daily-functioning-quality-of-life-across-several-different-regions
The incidence of hyperhidrosis was found to have exhibited variations from 0.13% in the UK to 0.28% in the USA, with a higher occurrence being seen among females. […] Likewise, the investigators reported that hyperhidrosis prevalence ranged from 2.8% 4.8% for the US population to 18.40% for Chinese inpatients, whereas the axillary hyperhidrosis prevalence fluctuated from 1.4% for the US population to 5.75% for Japanese employees and/or students. […] While limited evidence exists on the hyperhidrosis burden, particularly among those in Japan, it still was shown to be a substantial hindrance to patients’ overall daily functioning. […] Despite limited data, available evidence suggests that hyperhidrosis places physical, psychological, and economic burdens on the daily lives of individual patients, they wrote. The introduction of new treatments is expected to improve the medical environment of hyperhidrosis and reduce the burden on patients.
- #7https://www.termedia.pl/Hyperhidrosis-disease-aetiology-classification-and-r-nmanagement-in-the-light-of-modern-treatment-modalities,7,46948,1,1.html
Every hyperhidrosis manifestation in older patients, i.e. above 60 years old, should urge physicians to seek for secondary causes of the disease. […] Additionally, a correlation between the location of sweat overproduction and patients age was observed. Adolescents and young adults demonstrated the hyperhidrosis symptoms more often on palms, whereas adults around axillary areas.
- #7 Hyperhidrosis – Wikipediahttps://en.wikipedia.org/wiki/Hyperhidrosis
It is estimated that the incidence of focal hyperhidrosis may be as high as 2.8% of the population of the United States. […] It affects men and women equally, and most commonly occurs among people aged 25-64 years, though some may have been affected since early childhood. […] About 30-50% of people have another family member affected, implying a genetic predisposition. […] In 2006, researchers at Saga University in Japan reported that primary palmar hyperhidrosis maps to gene locus 14q11.2-q13.
- #7 Epidemiology of Primary Hyperhidrosis – Focus on Hyperhidrosishttps://www.medpagetoday.com/resource-centers/focus-hyperhidrosis/epidemiology-primary-hyperhidrosis/2281
A series of studies on patients treated by endoscopic thoracic sympathectomy (ETS) reported a family history in 35% and 56% of participants. […] A study of the familial aggregation of hyperhidrosis also suggested that the disorder may be more common than previously thought. […] Focal primary hyperhidrosis usually has an onset during childhood or adolescence. […] This 2016 study also showed that hyperhidrosis is often a lifelong struggle with symptom severity FAILING to lessen with age — 88% reported that symptoms have become worse or stayed the same over time. […] Key take-aways: primary Hh is relatively common, multifocal, and chronic with an onset in youth and an apparent genetic link — yet, diagnosis and treatment is often delayed for years.
- #7 Excessive Sweating (Hyperhidrosis) > Fact Sheets > Yale Medicinehttps://www.yalemedicine.org/conditions/excessive-sweating
Excessive sweating that can get in the way of daily life and cause skin infections. […] The condition affects about 3% of Americans. […] Hyperhidrosis tends to run in families. […] More people probably have hyperhidrosis than are diagnosed.
- #8 SciELO Brasil – Hyperhidrosis: prevalence and impact on quality of life Hyperhidrosis: prevalence and impact on quality of lifehttps://www.scielo.br/j/jbpneu/a/gxS3VxQSW3j7hX5MkLXDxqz/
Objective: To determine the prevalence of primary hyperhidrosis in the city of Botucatu, Brazil, and to evaluate how this disorder affects the quality of life in those suffering from it. […] A total of 4,133 residents, in 1,351 households, were surveyed. Excessive sweating was reported by 85 residents (prevalence = 2.07%), of whom 51 (60%) were female. […] Although the prevalence of self-reported excessive sweating was greater than 2%, the actual prevalence of primary hyperhidrosis in our sample was 0.93% and nearly 50% of the respondents with primary hyperhidrosis reported impaired quality of life. […] There are few data on the worldwide prevalence of hyperhidrosis, reported values ranging from 0.072% to 9%. […] In our study, the prevalence of hyperhidrosis after the application of a questionnaire by trained interviewers was above 2%, as observed by Strutton et al. However, after medical evaluation, 25% of the patients that reported excessive sweating actually showed normal sweating and 30% had SH. Consequently, more than half of the subjects that reported excessive sweating did not actually have PH. Therefore, after medical evaluation, the estimated prevalence of PH decreased to less than 1%.
- #8 Primary Hyperhidrosis: Understanding Its Impact and Exploring Treatment Optionshttps://www.rupahealth.com/post/primary-hyperhidrosis-understanding-its-impact-and-exploring-treatment-options
Studies have shown that about 30% to 50% of individuals with primary hyperhidrosis have a family history of the condition, suggesting a hereditary predisposition. […] Primary hyperhidrosis is a chronic condition characterized by excessive and uncontrollable sweating, affecting specific areas of the body such as the hands, feet, underarms, and face. […] A variety of management options are available, including topical antiperspirants, oral medications, iontophoresis, Botox injections, and surgical options for severe cases. […] Early intervention and support can make a substantial difference in managing the challenges of living with primary hyperhidrosis.
- #9 Epidemiology of Hyperhidrosis in Danish Blood Donors | HTML | Acta Dermato-Venereologicahttps://www.medicaljournals.se/acta/content/html/10.2340/00015555-3790
Hyperhidrosis (HH) is defined as pathologically increased sweat production that affects quality of life, which leaves a broad scope for interpretation. Thus, the prevalence of self-reported HH is 221% and the prevalence of hospital-diagnosed HH is 14%. The objectives of this study were therefore to estimate the prevalence of HH and to compare demographic, lifestyle, and socioeconomic parameters in individuals with and without self-reported or hospital-diagnosed HH. […] Overall, 2,794 of 30,808 blood donors had moderate-to-severe self-reported HH, which implied a prevalence of 9.07% (95% confidence interval (95% CI) 8.759.40). In contrast, 284 of 122,225 blood donors had hospital-diagnosed HH, which equated to a prevalence of 0.23% (95% CI 0.210.26). Self-reported HH was associated with overweight, smoking, reduced income, unemployed vs working and lower probability of short education vs high school. Hospital-diagnosed HH was not associated with any of the analysed parameters.
- #10 Hyperhidrosis prevalence and its impact on population – Hasimoto – Shanghai Chesthttps://shc.amegroups.org/article/view/5114/html
Hyperhidrosis is a disorder characterized by excessive sweating which beyond the physiological need for body thermoregulation. The prevalence data available in the literature are practically nonexistent up to the beginning of the 21st century. The prevalence found in the articles varied from 0.072% to 16.3%. As to the impact on the quality of life, all articles have shown that such disorder affects in some way the life of the individuals. The data available in the literature regarding the prevalence of hyperhidrosis in the world population are practically nonexistent until the beginning of the 21st century, therefore up to some time ago little was known about the number of individuals bearing this disorder. The bibliographic review was done by using the PubMed database (until January 10th 2019). Sixteen articles that evaluated the prevalence of hyperhidrosis were found in the research, 15 of them were published from the 21st century. The prevalence of hyperhidrosis found in the articles ranged from 0.072% to 16.3%. The first citation found in the literature about the prevalence of hyperhidrosis is from 1977. The first published work with methodological description was the one by Strutton et al. in 2004. In 2007 China published two studies about the prevalence of hyperhidrosis. The lowest prevalence of published hyperhidrosis was 0.072%, by Chu et al. The highest prevalence published among all published papers was the one by Augustin et al. in 2013. The most recent work about the prevalence of hyperhidrosis belongs to our group, published in 2018. The existing data of hyperhidrosis prevalence in the world population are well varied and questionable due to the heterogeneity of methodologies used in several studies. The impacts of hyperhidrosis in the quality of life of the individuals are well known in daily practice and are confirmed by means of the applied questionnaires aimed at measuring the severity and the interference of the disorder in the daily life of its patient.
- #11 SciELO Brasil – Hyperhidrosis: prevalence and impact on quality of life Hyperhidrosis: prevalence and impact on quality of lifehttps://www.scielo.br/j/jbpneu/a/gxS3VxQSW3j7hX5MkLXDxqz/
Objective: To determine the prevalence of primary hyperhidrosis in the city of Botucatu, Brazil, and to evaluate how this disorder affects the quality of life in those suffering from it. […] A total of 4,133 residents, in 1,351 households, were surveyed. Excessive sweating was reported by 85 residents (prevalence = 2.07%), of whom 51 (60%) were female. […] Although the prevalence of self-reported excessive sweating was greater than 2%, the actual prevalence of primary hyperhidrosis in our sample was 0.93% and nearly 50% of the respondents with primary hyperhidrosis reported impaired quality of life. […] There are few data on the worldwide prevalence of hyperhidrosis, reported values ranging from 0.072% to 9%. […] In our study, the prevalence of hyperhidrosis after the application of a questionnaire by trained interviewers was above 2%, as observed by Strutton et al. However, after medical evaluation, 25% of the patients that reported excessive sweating actually showed normal sweating and 30% had SH. Consequently, more than half of the subjects that reported excessive sweating did not actually have PH. Therefore, after medical evaluation, the estimated prevalence of PH decreased to less than 1%.